Medical Cannabis

Cannabis Products Unverified Claims to be Question by Authorities

Cannabis dependent people tend to become more dependent on it and they land up using it very often.  Cannabis is more than a recreational drug and it is used for many purposes other than smoking.  Scientific and medical potential of the drug has been reviewed by several experts. 

The chemistry of Cannabinoids is complex. There is a lot of difference between the psycho activity of CBD and THC. CBD and THC are the psychoactive elements in Cannabis.  It is THC that gets people to highs.

More than 100 Cannabinoids in Cannabis

David Rothenberg, co-founder of Mighty Self, wrote, Δ-THCV, for example, has been shown to have neuroprotective properties and to relieve symptoms of Parkinson’s disease in animal models.” With improved legalization, Cannabis based medications will expand.

Cannabinoids are wellness chemicals and there are more than 100 cannabinoids present in the cannabis plant. 

Contradictory Regulations Concerning the Cannabis

The Cannabinoids industry is gaining attention for the kind of health benefits it provides. There are contradictory regulations concerning the Cannabis. And, therefore, their position in the pharmaceutical industry is unclear. A significant amount of pre-clinical research has been undertaken by the US National Institutes of Health (NIH).  The active pharmaceutical ingredients in Cannabis are considered to be fundamentally illegal at the Federal Level in the US. 

It is not therefore easy to hire a research and development team to build upon a business development program for Cannabis derived Cannabinoid around the pharmaceutical pipeline.

Cannabis Products Unverified Claims 

Several pharmaceutical companies were making unverified Cannabidiol claims about their products and it found that the markets will become tightly regulated further on.  US authorities, such as the Food and Drug Administration (FDA) have begun issuing warning letters to such claims. When compared to Canada, the market claims will become more regulated in the US.

There is a lot of data about Cannabinoid being medically potent and biologically active.  It is expected that down 10 years from now, the long-term effects of the drug will be revealed.

Asian medical practitioners have been using Cannabis derived products for several 1000 years.  However, modern physicians are finding it difficult to identify the right strains of plant material considering their potency.  The potency varies from one strain to another. Since the potential level becomes unclear, patients tend to either haven an ineffective dose or overdose leading to intoxication.

Cannabis based blockchain technology platforms are helping in the process of tracking Cannabis strains from seed to end consumer.  Thus ensuring authenticity for potency of strain.

Sally Anderson

Sally is a Masters in Business Administration by education. After completing her post-graduation, Sally jumped the journalism bandwagon as a freelance journalist. Soon after that she landed a job of reporter and has been climbing the news industry ladder ever since to reach the post of editor.

Related Articles